The growing prevalence of UGIT surgeries, including bariatric procedures such as Roux-en-Y gastric bypass (RYGB) [3,4,5], sleeve gastrectomy [6, 7], and duodenal switch[8], as well as other surgeries like esophagectomy [9]and gastrectomy [10],Nissen fundoplication [11]has drawn attention to this condition [12]
This formulation combines CJC-1295 and Ipamorelin peptides in one injectable blend designed to support key physiological pathways associated with recovery, muscle maintenance, and overall metabolic function
To get a drug FDA approved, a company must conduct phase 1, 2 and 3 clinical trials proving safety and efficacy of the compound through a laborious, multi year and extremely costly process
Zuberbier T, Ensina LF, Gimenez-Arnau A, et al
By targeting two hormonal pathways, it offers a more comprehensive approach to managing both food intake and the bodys ability to burn fat